Melhores Cardiomiopatia dilatada médicos em Tailândia - TOP-3 médicos

Experience

Senior Medical Director
American Clinic, Demarest · Full-time
May 2024 – Present · 8 mos
Thailand

CEO
Imperium Bio@Capital
Aug 2021 – Present · 3 yrs 5 mos
Dubai, UAE

• Management
• Client Acquisition

General Director
R&D Company “Innovation Endovascular Technologies,” Skolkovo
2020 – Present · 5 yrs

• Healthcare Policy
• Project Implementation

General Manager
IMA Haddassah University Hospital Health Plus, Middle East
Dec 2020 – Oct 2021 · 11 mos

• Management
• Strategic Thinking

Chief Physician and Medical Director
Hadassah Medical Moscow, Skolkovo
Aug 2019 – Aug 2020 · 1 yr 1 mo
Moscow, Russia

Mais de 40 anos de experiência em cardiologia – O Dr. Ratanapunt é pioneiro em tratamentos não invasivos de doenças cardíacas no Bangkok Heart Center.

• Fundador do Bangkok Heart Center – o primeiro centro especializado em cardiologia da Tailândia
• Formado pela Universidade de Kyoto e pela Universidade de Hamburgo em cardiologia avançada
• Especializar-se em tratamentos não invasivos, incluindo terapias com células estaminais
• Certificado em Medicina Interna e Cardiologia

Wissarut Sakulpaptong, M.D., is a board-certified cardiologist and a cardiology staff member at King Chulalongkorn Memorial Hospital. He specializes in advanced echocardiography. His work includes transthoracic and transesophageal studies, strain analysis, 3D and stress echocardiography, and imaging for congenital heart disease. He also holds an M.Sc. (Medicine) from Chulalongkorn University.

His leadership roles include Chief Fellow (2024) and Chief Resident (2022). His awards include Second Prize at the 2025 Echocardiography Annual Scientific Meeting (Heart Association of Thailand), 2021 Outstanding Second-Year Resident, and 2017 Outstanding Medical Graduate. He developed an NSTEMI care pathway, a Screening Echocardiogram Project, and a Home-Visit Warfarin Clinic. He presented research on sepsis-induced myocardial dysfunction. He also contributed to Thailand’s 2022 migraine guideline.